Multiple screening assays including proteomic analysis, LC-MS/MS analysis, and the loss-of-function test indicated that TRAPPC4 is a predominant regulator of PD-L1, and a significantly positive correlation between the protein levels of TRAPPC4 and PD-L1 was demonstrated in murine and human colon cancer tissues. Here, CD274 is linked to colonic neoplasm.